|
2024
|
Invention
|
Antibody-drug conjugate targeting c-met and medical use thereof. An antibody-drug conjugate targe... |
|
|
Invention
|
Preparation method for kras g12d intermediate. A preparation method for a KRAS G12D intermediate.... |
|
|
Invention
|
Fibroblast activation protein ligand and use thereof. The present application relates to a fibrob... |
|
|
Invention
|
Method for treating prostate cancer. A method for treating prostate cancer; specifically, the use... |
|
|
Invention
|
Benzofuran derivative and preparation method for benzofuran derivative intermediate. The present ... |
|
|
Invention
|
Preparation method for formamide compounds. The present disclosure relates to a preparation metho... |
|
|
Invention
|
Anti-npr1 antibody and pharmaceutical use thereof. Provided are an anti-NPR1 antibody, a pharmace... |
|
|
Invention
|
Pharmaceutical composition comprising cephalosporin antibacterial compound. A pharmaceutical comp... |
|
|
Invention
|
Amorphous substance and crystal of dioxopiperidine compound or pharmaceutically acceptable salt t... |
|
|
Invention
|
Crystal form of lipoprotein compound and preparation method therefor. The present disclosure rela... |
|
|
Invention
|
Drug-loaded macromolecule of antifungal drug and preparation method therefor. The present disclos... |
|
|
Invention
|
Ligand targeting fibroblast activation protein. The present disclosure relates to a ligand target... |
|
|
Invention
|
Anti-tf antibody and anti-tf antibody-drug conjugate and medical use thereof. The present inventi... |
|
|
Invention
|
Intermediate for preparing oligonucleotide analog or salt thereof, and preparation method therefo... |
|
|
Invention
|
Crystalline form of nitrogen-containing tetracyclic compound and preparation method therefor. The... |
|
|
Invention
|
Antigen binding molecule specifically binding to egfr and muc1, drug conjugate thereof, and medic... |
|
|
Invention
|
Fused tetracyclic compound and preparation method therefor and use thereof in medicine. The prese... |
|
|
Invention
|
Use of anti-trop2 antibody combined with trop2-targeting drug in treating cancer. The present dis... |
|
|
Invention
|
Conjugate of anti-ror1 antibody and pbd compound, and preparation method therefor and use thereof... |
|
|
Invention
|
Pharmaceutically acceptable salt and crystal form of 1,4-dihydro-1,6-naphthyridine amide compound... |
|
|
Invention
|
Preparation method for indolizino[1,2-b]quinoline-10,13-dione derivative. The present disclosure ... |
|
|
Invention
|
Fap/4-1bb/cd40 binding molecule and medicinal use thereof. The present disclosure relates to an F... |
|
|
Invention
|
Anti-dll3 antibody, and antibody-drug conjugate and pharmaceutical use thereof. Provided are an a... |
|
|
Invention
|
Il-36r binding protein and medicinal use thereof. The present disclosure relates to an IL-36R bin... |
|
|
Invention
|
Crystalline form of sulfonamide derivative and preparation method therefor. The present disclosur... |
|
|
Invention
|
Pharmaceutically acceptable salt and crystal form of triazole compound, and preparation method th... |
|
|
Invention
|
Pharmaceutical composition containing eribulin derivative drug conjugate. The present disclosure ... |
|
|
Invention
|
Anti-her2 antibody-drug conjugate for treating breast cancer. Use of an anti-HER2 antibody-drug c... |
|
|
Invention
|
Tyrosinase-mediated protein site-specific conjugation and use thereof. The present disclosure rel... |
|
|
Invention
|
Method for preparing tetrahydro-1-naphthylamine and derivatives thereof. The present disclosure r... |
|
|
Invention
|
Substituted aminopyrimidine macrocyclic compounds, preparation method therefor, and medical uses ... |
|
|
Invention
|
Method for treating asthma by using tslp antibody. A method for treating asthma by using a TSLP a... |
|
2023
|
Invention
|
Anti-cd40 antibody-drug conjugate, preparation method therefor and medical use thereof. The prese... |
|
|
Invention
|
Composition of cd40-binding molecule and pharmaceutical use thereof. A composition of a CD40-bind... |
|
|
Invention
|
Crystal form of kras g12d inhibitor and preparation method therefor. The present disclosure relat... |
|
|
Invention
|
Phosphate ester prodrug of malt1 inhibitor. The present disclosure provides a phosphate ester pro... |
|
|
Invention
|
Cldn18.2/4-1bb binding protein and medical use thereof. The present disclosure relates to a CLDN1... |
|
|
Invention
|
Anti-her3 antibody-drug conjugate composition and pharmaceutical use thereof. The present inventi... |
|
|
Invention
|
Pharmaceutically acceptable salt of quinoline amine compound, and crystal form thereof and prepar... |
|
|
Invention
|
Anti-liv-1 antibody, drug conjugate thereof, and medical use thereof. Provided are a LIV-1 bindin... |
|
|
Invention
|
Pharmaceutical composition comprising bispecific antibody specifically binding to hgfr and egfr. ... |
|
|
Invention
|
Quinoline amine compound crystal form and preparation method therefor. The present disclosure rel... |
|
|
Invention
|
Pharmaceutically acceptable salt of nitrogen-containing heterocyclic compound, crystal form there... |
|
|
Invention
|
Crystalline form of pharmaceutically acceptable salt of pyrazolo heteroaryl derivative. The prese... |
|
|
Invention
|
Fused tricyclic compound, preparation method therefor, and pharmaceutical use thereof. The presen... |
|
|
Invention
|
Pharmaceutical composition comprising anti-rankl-ngf bispecific antibodies. The present disclosur... |
|
|
Invention
|
Cucurbituril compound and medical use thereof. The present disclosure relates to a cucurbituril c... |
|
|
Invention
|
Substituted aminopyrimidine compound, preparation method therefor, and medical use thereof. A sub... |
|
|
Invention
|
Crystal form of isoquinolinone compound and preparation method therefor. The present disclosure r... |
|
|
Invention
|
Composition comprising anti-masp2 antibody, and pharmaceutical use. The present disclosure relate... |
